New anemia drug gets China approval
ZHENG YIRAN Roxadustat, a domestically developed Class 1 medicine, received marketing approval from the National Medical Products Administration on Tuesday, a milestone for China’s biopharmaceutical research and development industry.
Read latest China Daily (Canada) online.
Newspapers from Canada
Newspapers in English